| Ionic liquid-based aqueous two-phase extraction of selected proteins Y Pei, J Wang, K Wu, X Xuan, X Lu Separation and Purification Technology 64 (3), 288-295, 2009 | 504 | 2009 |
| Impact of MCP-1 in atherosclerosis J Lin, V Kakkar, X Lu Current pharmaceutical design 20 (28), 4580-4588, 2014 | 221 | 2014 |
| Impact of IL-12 in Cancer X Lu Current cancer drug targets 17 (8), 682-697, 2017 | 106 | 2017 |
| Preferential antagonism of the interactions of the integrin αIIbβ3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence … X Lu, JA Williams, JJ Deadman, GP Salmon, VV Kakkar, JM Wilkinson, ... Biochemical Journal 304 (3), 929-936, 1994 | 86 | 1994 |
| The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy X Lu, D Lu, M Scully, V Kakkar Perspectives in medicinal chemistry 2, 1177391X0800200003, 2008 | 84 | 2008 |
| Integrins in drug targeting-RGD templates in toxins X Lu, D Lu, MF Scully, VV Kakkar Current pharmaceutical design 12 (22), 2749-2769, 2006 | 69 | 2006 |
| Three-dimensional structure of the RGD-containing neurotoxin homologue dendroaspin MJ Sutcliffe, M Jaseja, EI Hyde, X Lu, JA Williams Nature Structural Biology 1 (11), 802-807, 1994 | 67 | 1994 |
| Impact of matrix metalloproteinases on atherosclerosis J Lin, V Kakkar, X Lu Current drug targets 15 (4), 442-453, 2014 | 65 | 2014 |
| The role of heat shock protein (HSP) in atherosclerosis: Pathophysiology and clinical opportunities X Lu, V Kakkar Current medicinal chemistry 17 (10), 957-973, 2010 | 65 | 2010 |
| Three‐dimensional structure of the RGD‐containing snake toxin albolabrin in solution, based on 1H NMR spectroscopy and simulated annealing calculations KJ SMITH, M JASEJA, X LU, JA WILLIAMS, EVAI HYDE, IANP TRAYER International Journal of Peptide and Protein Research 48 (3), 220-228, 1996 | 59 | 1996 |
| Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice X Lu, D Chen, V Endresz, M Xia, I Faludi, K Burian, A Szabo, A Csanadi, ... Atherosclerosis 212 (2), 472-480, 2010 | 57 | 2010 |
| Substitutions of Proline 42 to Alanine and Methionine 46 to Asparagine around the RGD Domain of the Neurotoxin Dendroaspin Alter Its Preferential Antagonism to That Resembling … X Lu, S Rahman, VV Kakkar, KS Authi Journal of Biological Chemistry 271 (1), 289-294, 1996 | 56 | 1996 |
| Solid-phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the alpha v beta 3 receptor C Denis, JA Williams, X Lu, D Meyer, D Baruch | 51 | 1993 |
| ADAM proteins-therapeutic potential in cancer X Lu, D Lu, M Scully, V Kakkar Current Cancer Drug Targets 8 (8), 720-732, 2008 | 50 | 2008 |
| The role of exosomes and exosome-derived microRNAs in atherosclerosis X Lu Current pharmaceutical design 23 (40), 6182-6193, 2017 | 47 | 2017 |
| Snake venom metalloproteinase containing a disintegrin-like domain, its structure-activity relationships at interacting with integrins X Lu, D Lu, MF Scully, VV Kakkar Current Medicinal Chemistry-Cardiovascular & Hematological Agents 3 (3), 249-260, 2005 | 47 | 2005 |
| Inflammasome and atherogenesis X Lu, V Kakkar Current pharmaceutical design 20 (1), 108-124, 2014 | 45 | 2014 |
| The integrin αIIbβ3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics … S Rahman, X Lu, VV Kakkar, KS Authi Biochemical Journal 312 (1), 223-232, 1995 | 43 | 1995 |
| Mucosal Tolerance to a Combination of ApoB and HSP60 Peptides Controls Plaque Progression and Stabilizes Vulnerable Plaque in Apobtm2SgyLdlrtm1Her/J … L Mundkur, R Mukhopadhyay, S Samson, M Varma, D Kale, D Chen, ... PLoS One 8 (3), e58364, 2013 | 42 | 2013 |
| Dendroaspin: A potent integrin receptor inhibitor from the venoms of Dendroaspis viridis and D. jamesonii JA Williams, X LU, S RAHMAN, C KEATING, V KAKKAR Biochemical Society Transactions 21 (1), 73S-73S, 1993 | 41 | 1993 |
